GO
Loading...

Cramer's Mad Dash: PBYI could quadruple

Wednesday, 23 Jul 2014 | 9:28 AM ET

Jim Cramer explains what to watch ahead of the open, including Puma Biotechnology. Cramer says the stock could quadruple due to the results of a new drug trial.